Conecte-se

Bibliografias temáticas / Postoperative cancer therapy / Artigos de revistas

Siga este link para ver outros tipos de publicações sobre o tema: Postoperative cancer therapy.

Artigos de revistas sobre o tema "Postoperative cancer therapy"

Autor: Grafiati

Publicado: 7 de junho de 2025

Última modificação: 2 de agosto de 2025

Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos

Selecione um tipo de fonte:

Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Postoperative cancer therapy".

Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.

Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.

Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.

1

del Regato, J. A. "Breast cancer: postoperative radiation therapy." Radiology 157, no. 1 (1985): 267–68. http://dx.doi.org/10.1148/radiology.157.1.4034974.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

2

Funakoshi, Yasunobu, Shin-Ichi Takeda, Noriyoshi Sawabata, Yoshitomo Okumura, and Hajime Maeda. "Long-Term Pulmonary Function after Lobectomy for Primary Lung Cancer." Asian Cardiovascular and Thoracic Annals 13, no. 4 (2005): 311–15. http://dx.doi.org/10.1177/021849230501300404.

Texto completo da fonte

Resumo:

The aim of this study was to investigate the factors affecting long-term postoperative pulmonary function with a view to increasing the application of combined resection, bronchoplasty, and induction therapy. Results in 80 patients who underwent lobectomy for primary lung cancer were analyzed. Predicted postoperative pulmonary function was calculated using the formula: postoperative predicted function = preoperative function × [1 − (b − n) /(42 − n)], where n and b are the numbers of obstructed segments and total segments, respectively, in the resected lobe. Spirometry was performed serially o

Estilos ABNT, Harvard, Vancouver, APA, etc.

3

Murthy, Vedang, Sayan Kundu, Tanweer Shahid, et al. "Postoperative Radiotherapy in Head and Neck Cancer." An International Journal of Otorhinolaryngology Clinics 2, no. 1 (2010): 43–51. http://dx.doi.org/10.5005/jp-journals-10003-1016.

Texto completo da fonte

Resumo:

Abstract Though early stage head and neck cancers can be cured either by surgery or radiation, patients with locally advanced disease continues to pose a therapeutic challenge. Locoregional failure is the major cause of death in head and neck cancers. As the outcome of locally advanced head and neck cancer is less than promising, a combined modality approach is generally undertaken in this group of patients. The combination of surgery, radiation and more recently, chemotherapy and targeted therapy can improve outcomes in locally advanced head and neck cancer patients. This overview discusses t

Estilos ABNT, Harvard, Vancouver, APA, etc.

4

Ku, Geoffrey Y., and David H. Ilson. "Adjuvant (Postoperative) Therapy for Esophageal Cancer." Thoracic Surgery Clinics 23, no. 4 (2013): 525–33. http://dx.doi.org/10.1016/j.thorsurg.2013.07.008.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

5

Teshima, Teruki, Masashi Chatani, Toshihiko Inoue, Eiji Kurokawa, Ken Kodama, and Osamu Doi. "Postoperative radiation therapy for lung cancer." Haigan 27, no. 1 (1987): 11–21. http://dx.doi.org/10.2482/haigan.27.11.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

6

Tepper, Joel E., Alfred M. Cohen, William C. Wood, Erica L. Orlow, and Stephen E. Hedberg. "Postoperative radiation therapy of rectal cancer." International Journal of Radiation Oncology*Biology*Physics 13, no. 1 (1987): 5–10. http://dx.doi.org/10.1016/0360-3016(87)90252-5.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

7

Penberthy, David R., Tyvin A. Rich, and Reid B. Adams. "Postoperative adjuvant therapy for pancreatic cancer." Seminars in Surgical Oncology 21, no. 4 (2003): 256–60. http://dx.doi.org/10.1002/ssu.10044.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

8

Ganev, Tosho. "OVERALL AND CANCER-SPECIFIC SURVIVAL OF HIGH-RISK PROSTATE CANCER – IMPACT OF ADJUVANT THERAPY AFTER RADICAL PROSTATECTOMY." Journal of IMAB - Annual Proceeding (Scientific Papers) 29, no. 4 (2023): 5188–91. http://dx.doi.org/10.5272/jimab.2023294.5188.

Texto completo da fonte

Resumo:

Purpose: The study examines the survival of patients with high-risk prostate cancer in order to find a relationship between survival and the type of postoperative therapy. Materials/Methods: The object of the study were 872 patients who underwent radical prostatectomy in the Clinic of Urology in "St. Anna - Varna" Hospital for the period from April 17, 1996, until November 25, 2022. Postoperatively, some patients were additionally subjected to hormonal therapy (referred to as "dual therapy" in the text), and others to hormonal and radiotherapy (referred to as "triple therapy"). Results: Overal

Estilos ABNT, Harvard, Vancouver, APA, etc.

9

Jackeline, Rangel. "Importance of Physical Therapy in Breast Cancer Survivors." Women's Health Science Journal 4, no. 2 (2020): 1–7. http://dx.doi.org/10.23880/whsj-16000150.

Texto completo da fonte

Resumo:

Women diagnosed with breast cancer have had a significant increase in life expectancy in recent years. However, many of these women are living with chronic complications resulting from treatment. It is common during and after the treatment of breast cancer, particularly at the trunk and upper limb (pain, movement disorders, among others). Physical therapy may play an important role in the immediate and late postoperative period of breast cancer surgery where it can be considered one of the main preventive agents for disorders after surgery. Physical therapy is considered an effective intervent

Estilos ABNT, Harvard, Vancouver, APA, etc.

10

Chai, Tianci, Zhimin Shen, Peipei Zhang, et al. "Postoperative adjuvant therapy for resectable esophageal cancer." Medicine 98, no. 20 (2019): e15485. http://dx.doi.org/10.1097/md.0000000000015485.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

11

Ogoshi, Kyoji, Yasuo Kajiura, Kenji Nakamura, et al. "Postoperative adjuvant therapy for resectable gastric cancer." Annals of Cancer Research and Therapy 3, no. 2 (1994): 121–25. http://dx.doi.org/10.4993/acrt1992.3.121.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

12

Goldberg, Neal, and Richard E. Peschel. "Postoperative abdominopelvic radiation therapy for ovarian cancer." International Journal of Radiation Oncology*Biology*Physics 14, no. 3 (1988): 425–29. http://dx.doi.org/10.1016/0360-3016(88)90255-6.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

13

Nagorsky, Matthew J., and Donald G. Sessions. "Laser Resection for Early Oral Cavity Cancer." Annals of Otology, Rhinology & Laryngology 96, no. 5 (1987): 556–60. http://dx.doi.org/10.1177/000348948709600515.

Texto completo da fonte

Resumo:

Laser excision of early selected cancers of the oral cavity and pharynx is a well accepted and reported treatment. Postoperative radiation therapy is employed in patients with unfavorable pathologic findings and in patients expected to have a high recurrence and metastatic rate. In most patients the combination of laser excision and postoperative radiation therapy is well tolerated and results in satisfactory healing, excellent tumor control, and high-level posttreatment function. This report discusses the treatment and results in 28 patients treated for early cancer of the oral cavity and pha

Estilos ABNT, Harvard, Vancouver, APA, etc.

14

Xue, Xinyuan, Amerull Azman, Cuicui Zhang, Yangjia Chen, Jun Ni, and Zhi-Yong Wang. "Rehabilitation for complicated dysphagia after synchronous head-and-neck and esophageal cancer surgery: A case report." Medicine 103, no. 45 (2024): e40338. http://dx.doi.org/10.1097/md.0000000000040338.

Texto completo da fonte

Resumo:

Rationale: Surgical intervention for synchronous head-and-neck and esophageal cancers often results in complex dysphagia, significantly affecting postoperative quality of life. Swallowing dysfunction may become permanent or worsen, with potential impacts on noncancer-related mortality. Patient concerns: We report a rare case of multiple synchronous squamous cell carcinomas of the head and neck (tonsillar and epiglottic cancer) along with esophageal cancer, presenting for dysphagia rehabilitation following surgery. Diagnoses: Comprehensive evaluations—including magnetic resonance imaging, laryn

Estilos ABNT, Harvard, Vancouver, APA, etc.

15

Minsky, B. D., A. M. Cohen, N. Kemeny, et al. "Combined modality therapy of rectal cancer: decreased acute toxicity with the preoperative approach." Journal of Clinical Oncology 10, no. 8 (1992): 1218–24. http://dx.doi.org/10.1200/jco.1992.10.8.1218.

Texto completo da fonte

Resumo:

PURPOSE We compared the combined radiation therapy (RT) plus chemotherapy segments of two separate parallel phase I trials to determine if combined pelvic RT, fluorouracil (5-FU), and high-dose leucovorin (LV) had less acute toxicity when delivered preoperatively versus postoperatively in patients with rectal cancer. PATIENTS AND METHODS Patients with unresectable disease received preoperative RT plus LV and 5-FU followed by surgery and postoperative LV and 5-FU. Patients with resectable disease received identical doses, techniques, and schedules of RT and LV and 5-FU except all therapy was de

Estilos ABNT, Harvard, Vancouver, APA, etc.

16

Ortabaeva, D. R., A. D. Zikiryakhodzhaev, E. A. Rasskazova, E. K. Saribekyan, and A. D. Kaprin. "Long-term oncological outcomes of organ-sparing treatment of patients with early breast cancer aged 65 years and older who had no postoperative radiation therapy." Tumors of female reproductive system 18, no. 3 (2022): 24–28. http://dx.doi.org/10.17650/1994-4098-2022-18-3-24-28.

Texto completo da fonte

Resumo:

Postoperative radiation therapy after breast-conserving surgery is a standard method of treating breast cancer, but recently the issue of its de-escalation in patients older than 65 due to concomitant pathology, lower life expectancy and possible development of post-radiation complications has been discussed. The results of some foreign studies prove the absence of a statistically significant difference in relapse-free and overall survival in patients with early breast cancer older than 65 years with relatively favorable clinical and morphological characteristics without postoperative radiatio

Estilos ABNT, Harvard, Vancouver, APA, etc.

17

Androutsopoulos, Georgios, and Georgios Decavalas. "Endometrial cancer: current treatment strategies." World J Oncol Res 1, no. 1 (2014): 1–4. https://doi.org/10.5281/zenodo.6060536.

Texto completo da fonte

Resumo:

Endometrial cancer (EC) is the most common malignancy of the female genital tract. It occurs primarily in postmenopausal women. Systematic surgical staging is the baseline therapy, for most patients with EC. That therapeutic approach allows a more clear decision for stage related postoperative adjuvant therapy. Pelvic and para-aortic lymphadenectomy is essential for surgical staging in patients with EC. Postoperative adjuvant radiotherapy in EC patients includes vaginal brachytherapy and external radiotherapy. Postoperative adjuvant chemotherapy is the mainstay of treatment for EC patients wit

Estilos ABNT, Harvard, Vancouver, APA, etc.

18

Anderson, Garrett, Maryam Ebadi, Kim Vo, Jennifer Novak, Ameish Govindarajan, and Arya Amini. "An Updated Review on Head and Neck Cancer Treatment with Radiation Therapy." Cancers 13, no. 19 (2021): 4912. http://dx.doi.org/10.3390/cancers13194912.

Texto completo da fonte

Resumo:

The complexity of head and neck cancers (HNC) mandates a multidisciplinary approach and radiation therapy (RT) plays a critical role in the optimal management of patients with HNC, either as frontline or adjuvant treatment postoperatively. The advent of both definitive and post-operative RT has significantly improved the outcomes of patients with HNC. Herein, we discuss the role of postoperative RT in different subtypes of HNC, its side effects, and the importance of surveillance. The treatment regions discussed in this paper are the oral cavity, nasopharynx, paranasal sinus cavity, oropharynx

Estilos ABNT, Harvard, Vancouver, APA, etc.

19

Labianca, R., P. Sburlati, A. Quadri, and M. C. Garassino. "Perioperative or postoperative therapy for resectable gastric cancer?" Annals of Oncology 19 (July 2008): v99—v102. http://dx.doi.org/10.1093/annonc/mdn320.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

20

Vanderveen, Kimberly A., Steven L. Chen, Daixin Yin, Rosemary D. Cress, and Richard J. Bold. "Benefit of postoperative adjuvant therapy for pancreatic cancer." Cancer 115, no. 11 (2009): 2420–29. http://dx.doi.org/10.1002/cncr.24269.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

21

Olifia Nafa Jelita, Mulia Hakam, Rondhianto, and Umayanah. "Nursing Care of Acute Pain in Rectal Cancer Patients Using Non-Pharmacological Approach with Benson Therapy: A Case Study." Jurnal Kegawatdaruratan Medis Indonesia 2, no. 1 (2023): 90–101. http://dx.doi.org/10.58545/jkmi.v2i1.63.

Texto completo da fonte

Resumo:

Pain is the main problem experienced by many postoperative patients. One of the therapies for patients with rectal cancer is surgery, so patients with rectal cancer also feel pain after getting surgery. > 80% of patients experience postoperative pain, but appropriate pain management only occurs in approximately 30-50%. Benson's relaxation therapy reduces pain intensity in postoperative patients without causing side effects. This study aims to analyze benson therapy to reduce pain in postoperative surgery for patients with rectum cancer. The method used in this research is a descriptive case

Estilos ABNT, Harvard, Vancouver, APA, etc.

22

Mahendra, I. Nyoman Bayu, and William Alexander Setiawan. "PARP Inhibitor for Ovarian Cancer Therapy." European Journal of Medical and Health Sciences 4, no. 6 (2022): 1–7. http://dx.doi.org/10.24018/ejmed.2022.4.6.1477.

Texto completo da fonte

Resumo:

Almost all ovarian cancers are comprised of epithelial ovarian cancer (EOC). Approximately 80% of patients with EOC initially respond to standard cytoreductive therapy and postoperative platinum-based chemotherapy. However, due to drug resistance in high-grade serous ovarian cancer (HGSOC), recurrence is almost inevitable. Recently, the nuclear enzyme poly (ADP ribose) polymerase (PARP) represents a surprisingly new target in EOC therapy. Inhibitors of PARP have demonstrated promising efficacy in the treatment of EOC. Studies on Olaparib, in particular, hastened its approval in the USA and Eur

Estilos ABNT, Harvard, Vancouver, APA, etc.

23

Myles, Bevan H., Caimiao Wei, Ritsuko Komaki, et al. "Effect of technologic advancements in radiotherapy on postoperative pulmonary complications after neoadjuvant chemoradiation in esophageal cancer." Journal of Clinical Oncology 30, no. 4_suppl (2012): 110. http://dx.doi.org/10.1200/jco.2012.30.4_suppl.110.

Texto completo da fonte

Resumo:

110 Background: Although 3D conformal radiation therapy (3D-CRT) is currently the de facto standard for the treatment of esophageal cancers, technologies such as Intensity Modulated Radiation Therapy (IMRT) or Proton Beam Therapy (PBT) are increasingly being used, but the evidence for the clinical benefits of these technologies are lacking. We hypothesized that radiation technology influences perioperative complications in esophageal cancer patients treated with neoadjuvant chemoradiation. Methods: We evaluated 423 patients (3D-CRT (n=208, 1998-2008), IMRT (n=165, 2004-2011), and PBT (n=50, 20

Estilos ABNT, Harvard, Vancouver, APA, etc.

24

Sada, Yvonne, Brandon George Smaglo, Hop Sanderson Tran Cao, et al. "Trends in multimodality therapy for gastric cancer post-MAGIC." Journal of Clinical Oncology 35, no. 4_suppl (2017): 148. http://dx.doi.org/10.1200/jco.2017.35.4_suppl.148.

Texto completo da fonte

Resumo:

148 Background: Althoughmultimodality therapy (MMT) is recommended for most patients with resectable gastric cancer, no single approach has been established as standard. As such, little is known about current national practice patterns and MMT treatment sequencing for patients with gastric cancer. Methods: This was a retrospective cohort study of ≥ T2 and/or node positive gastric cancer patients treated with MMT using the National Cancer Database (2006-2012). Patients were categorized based on type of MMT (chemotherapy, concurrent chemoradiation (cXRT), or both chemotherapy and cXRT) and treat

Estilos ABNT, Harvard, Vancouver, APA, etc.

25

Link, Staib, Kornmann, et al. "Surgery, Radio- and Chemo- therapy for Multimodal Treatment of Rectal Cancer." Swiss Surgery 7, no. 6 (2001): 256–74. http://dx.doi.org/10.1024/1023-9332.7.6.256.

Texto completo da fonte

Resumo:

The possibilities and results of multimodal treatment in rectal cancer were reviewed with respect to the results of surgical treatment only. Based on the results of 4 studies, reducing local relapse rates and increasing long term survival rates significantly, postoperative radiochemotherapy (RCT) + chemotherapy (CT) should remain the recommended standard for R0 resected UICC II and III rectal cancers. The addition of RT to adjuvant CT reduces local relapses without significant impact on survival (NSABP R-02). Vice versa, the addition of CT to RT or an improved CT in the RCT-concept prolongs su

Estilos ABNT, Harvard, Vancouver, APA, etc.

26

Lin, Steven H., Kaiping Liao, Xiudong Lei, et al. "Health Care Resource Utilization for Esophageal Cancer Using Proton versus Photon Radiation Therapy." International Journal of Particle Therapy 9, no. 1 (2022): 18–27. http://dx.doi.org/10.14338/ijpt-22-00001.1.

Texto completo da fonte

Resumo:

Abstract Purpose In patients treated with chemoradiation for esophageal cancer (EC), randomized trial data demonstrate that proton beam therapy (PBT) reduces toxicities and postoperative complications (POCs) compared with intensity-modulated radiation therapy (IMRT). However, whether radiation therapy modality affects postoperative health care resource utilization remains unknown. Materials and Methods We examined 287 patients with EC who received chemoradiation (prescribed 50.4 Gy/GyE) followed by esophagectomy, including a real-world observational cohort of 237 consecutive patients treated f

Estilos ABNT, Harvard, Vancouver, APA, etc.

27

D'Angio, Giulio J. "Pre- or Postoperative Therapy for Wilms’ Tumor?" Journal of Clinical Oncology 26, no. 25 (2008): 4055–57. http://dx.doi.org/10.1200/jco.2008.16.5316.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

28

Willett, Christopher G., Joel E. Tepper, Donald S. Kaufman, et al. "Adjuvant Postoperative Radiation Therapy For Rectal Adenocarcinoma." American Journal of Clinical Oncology 15, no. 5 (1992): 371–75. http://dx.doi.org/10.1097/00000421-199210000-00001.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

29

Moya, J., F. Gomez, C. Asensio, et al. "Postoperative radiation therapy in soft tissue sarcomas." European Journal of Cancer 29 (January 1993): S188. http://dx.doi.org/10.1016/0959-8049(93)91672-8.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

30

Fisher, B., J. Bryant, N. Wolmark, et al. "Effect of preoperative chemotherapy on the outcome of women with operable breast cancer." Journal of Clinical Oncology 16, no. 8 (1998): 2672–85. http://dx.doi.org/10.1200/jco.1998.16.8.2672.

Texto completo da fonte

Resumo:

PURPOSE To determine, in women with primary operable breast cancer, if preoperative doxorubicin (Adriamycin) and cyclophosphamide (Cytoxan; AC) therapy yields a better outcome than postoperative AC therapy, if a relationship exists between outcome and tumor response to preoperative chemotherapy, and if such therapy results in the performance of more lumpectomies. PATIENTS AND METHODS Women (1,523) enrolled onto National Surgical Adjuvant Breast and Bowel Project (NSABP) B-18 were randomly assigned to preoperative or postoperative AC therapy. Clinical tumor response to preoperative therapy was

Estilos ABNT, Harvard, Vancouver, APA, etc.

31

Fisher, B., J. Bryant, N. Wolmark, et al. "Effect of preoperative chemotherapy on the outcome of women with operable breast cancer." Journal of Clinical Oncology 41, no. 10 (2023): 1795–808. http://dx.doi.org/10.1200/jco.22.02571.

Texto completo da fonte

Resumo:

PURPOSE To determine, in women with primary operable breast cancer, if preoperative doxorubicin (Adriamycin) and cyclophosphamide (Cytoxan; AC) therapy yields a better outcome than postoperative AC therapy, if a relationship exists between outcome and tumor response to preoperative chemotherapy, and if such therapy results in the performance of more lumpectomies. PATIENTS AND METHODS Women (1,523) enrolled onto National Surgical Adjuvant Breast and Bowel Project (NSABP) B-18 were randomly assigned to preoperative or postoperative AC therapy. Clinical tumor response to preoperative therapy was

Estilos ABNT, Harvard, Vancouver, APA, etc.

32

Milosevic, Nikola, Suzana Stojanovic-Rundic, Srdjan Milanovic, et al. "Gastroesophageal junction cancer - current topic and treatment dilemmas." Srpski arhiv za celokupno lekarstvo, no. 00 (2024): 52. http://dx.doi.org/10.2298/sarh240423052m.

Texto completo da fonte

Resumo:

Treatment of gastroesophageal junction carcinomas have been debated for many years. This type of carcinomas has been classified as either gastric or esophageal carcinomas until Siewert's classification was established and they were defined as a distinct entity. Risk factors for development of these cancers are gastroesophageal reflux and Barrett's esophagus, obesity, Helycobacter pylori infection, smoking, and alcohol. Symptoms of this disease include retrosternal pain, dysphagia to aphagia and weight loss. Esophagogastroduodenoscopy with biopsy and pathohistological verification as well as CT

Estilos ABNT, Harvard, Vancouver, APA, etc.

33

Khurshid, Arif, Hany Sharra, Abeer Alsulaimani, et al. "Triple Negative and HER-2 Positive Breast Cancer Outcome After Neoadjuvant." Journal of Pioneering Medical Sciences 14, no. 06 (2025): 129–37. https://doi.org/10.47310/jpms2025140618.

Texto completo da fonte

Resumo:

Background: Understanding the prevalence and nature of surgical outcomes and complications in TNBC and HER2-Positive breast cancer patients can guide clinicians in optimizing treatment strategies, improving postoperative care and ultimately enhancing the overall quality of care for breast cancer patients. This research aims to evaluate and compare the prevalence of various surgical outcomes and postoperative complications in patients with Triple-Negative Breast Cancer (TNBC) and HER2-Positive Breast Cancer who have undergone Neoadjuvant Therapy (NAT). Materials and Methods: A retrospective coh

Estilos ABNT, Harvard, Vancouver, APA, etc.

34

Androutsopoulos, Georgios, Charalampos Vitsas, Nikolaos Thanatsis, Georgios Michail, Emmanouil Terzakis, and Georgios Decavalas. "Clinical characteristics and current therapeutic approach of patients with synchronous primary endometrial and ovarian cancers." Hel J Obst Gynecol 13, no. 4 (2014): 109–14. https://doi.org/10.5281/zenodo.6012619.

Texto completo da fonte

Resumo:

Synchronous primary endometrial and ovarian cancers are relatively uncommon in general population. Although their pathogenesis still remains unclear, embryologic, hormonal, genetic or other phenomena may be responsible for the development of synchronous primary endometrial and ovarian cancers. The most common symptoms and signs in those patients, are: abnormal uterine bleeding, abdominal/pelvic pain and abdominal/pelvic mass. For most patients with synchronous primary endometrial and ovarian cancers, systematic surgical staging is the baseline therapy and includes: total abdominal hysterectomy

Estilos ABNT, Harvard, Vancouver, APA, etc.

35

Kadowaki, Daisuke, Shinji Kuroda, Makoto Matsumoto, et al. "Abstract 954: Preoperative p53-armed oncolytic virus therapy enhances the efficacy of postoperative adjuvant ICI therapy." Cancer Research 85, no. 8_Supplement_1 (2025): 954. https://doi.org/10.1158/1538-7445.am2025-954.

Texto completo da fonte

Resumo:

Abstract Background: In recent years, the importance of perioperative treatment in cancer therapy has increased, and postoperative adjuvant therapies using immune checkpoint inhibitors (ICIs) have been applied clinically in multiple cancer types. However, the efficacy of ICIs as monotherapy is often limited. We have developed a telomerase-specific oncolytic virus (OV), OBP-301, and its p53 gene-armed derivative, OBP-702. OBP-301 is currently undergoing clinical trials. Previous studies have demonstrated enhanced antitumor immunity, including an increase in CD8+ T cells following OV administrat

Estilos ABNT, Harvard, Vancouver, APA, etc.

36

Nevala-Plagemann, Christopher Duane, Samual Francis, Courtney Christine Cavalieri, Shane Lloyd, and Ignacio Garrido-Laguna. "The effect of adjuvant chemotherapy in patients without local nodal metastases following neoadjuvant chemoradiotherapy and esophagectomy for locally advanced esophageal cancer." Journal of Clinical Oncology 36, no. 4_suppl (2018): 111. http://dx.doi.org/10.1200/jco.2018.36.4_suppl.111.

Texto completo da fonte

Resumo:

111 Background: Neoadjuvant chemoradiation therapy (CRT) followed by esophagectomy is the current standard of care for patients with locally advanced esophageal cancer. The potential benefit of additional postoperative chemotherapy is still under investigation. In this study, we utilized the National Cancer Database to assess the effect of adjuvant chemotherapy in patients who were found to have node negative disease (pN0) following surgery. Methods: Patients with locally advanced esophageal cancer who received neoadjuvant CRT followed by esophagectomy from 2004 to 2014 were retrospectively id

Estilos ABNT, Harvard, Vancouver, APA, etc.

37

Skoropad, V. Yu, D. D. Kudryavtsev, P. V. Sokolov, S. A. Ivanov, and A. D. Kaprin. "Surgical management of cancer of the stomach and gastroesophageal junction after neoadjuvant therapy: the experience of the MRRC and literature review." Siberian journal of oncology 22, no. 1 (2023): 101–9. http://dx.doi.org/10.21294/1814-4861-2023-22-1-101-109.

Texto completo da fonte

Resumo:

Itroduction. Gastric cancer incidence and mortality rates remain very high worldwide, including the Russian Federation. More than 50 % of gastric cancers are locally advanced at presentation [1]. Perioperative or adjuvant chemotherapy is a standard treatment for gastric cancer patients. The use of neoadjuvant chemoradiotherapy is considered very promising.Material and Methods. We present the analysis of the results of surgical treatment of cancer of the stomach and gastrooesophageal junction after various options of neoadjuvant therapy: chemotherapy, chemoradiotherapy, and their combinations.

Estilos ABNT, Harvard, Vancouver, APA, etc.

38

Willett, C. G., C. Y. Fung, D. S. Kaufman, J. Efird, and P. C. Shellito. "Postoperative radiation therapy for high-risk colon carcinoma." Journal of Clinical Oncology 11, no. 6 (1993): 1112–17. http://dx.doi.org/10.1200/jco.1993.11.6.1112.

Texto completo da fonte

Resumo:

PURPOSE This study examines the experience of patients treated with postoperative radiation therapy after resection of high-risk colon carcinoma in an effort to assess the potential role of this modality in combination with current systemic therapies. PATIENTS AND METHODS From 1976 to 1989, 203 patients received postoperative radiation therapy with and without concurrent fluorouracil (5-FU) chemotherapy following resection of modified Astler-Coller B2, B3, C2, and C3 colon tumors. Of the 203 patients, 30 (15%) were identified as having residual local tumor after subtotal resection, whereas 173

Estilos ABNT, Harvard, Vancouver, APA, etc.

39

Stevens, G., and I. Firth. "Postoperative radiation therapy in locally-advanced melanoma." Melanoma Research 7, Supplement 1 (1997): S18. http://dx.doi.org/10.1097/00008390-199706001-00060.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

40

Rio, Aditya Kurniawan. "Vitamin C Administration in Breast Cancer After Surgery Treatment : A Review." International Journal Of Medical Science And Clinical Research Studies 03, no. 03 (2023): 591–96. https://doi.org/10.5281/zenodo.7788620.

Texto completo da fonte

Resumo:

<strong>Introduction : </strong>Breast cancer is still the most common type of cancer, and surgery is still an alternative available. Postoperative care for breast cancer is an action that must be evaluated from a variety of perspectives.   <strong>Methods : </strong>The information retrieval feature of the PubMed and Cambridge Core literature search engines was used to find review of literature articles for this journal. The periodicals on which the literature was predicated were obtained.   <strong>Result </strong>Vitamin C has various functions in cases of breast ca

Estilos ABNT, Harvard, Vancouver, APA, etc.

41

Zeng, Zhi-Ming, Ning Mo, Jie Zeng, et al. "Advances in postoperative adjuvant therapy for primary liver cancer." World Journal of Gastrointestinal Oncology 14, no. 9 (2022): 1604–21. http://dx.doi.org/10.4251/wjgo.v14.i9.1604.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

42

Decker, Roy H., and Lynn D. Wilson. "Postoperative Radiation Therapy for Non-Small Cell Lung Cancer." Seminars in Thoracic and Cardiovascular Surgery 20, no. 3 (2008): 184–87. http://dx.doi.org/10.1053/j.semtcvs.2008.09.004.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

43

Yao, J. C., and J. A. Ajani. "Therapy of localized gastric cancer: preoperative and postoperative approaches." Annals of Oncology 13 (October 2002): 7–12. http://dx.doi.org/10.1093/annonc/mdf632.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

44

Minsky, Bruce D., Warren E. Enker, Alfred M. Cohen, and Gregory Lauwers. "Local Excision and Postoperative Radiation Therapy for Rectal Cancer." American Journal of Clinical Oncology 17, no. 5 (1994): 411–16. http://dx.doi.org/10.1097/00000421-199410000-00011.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

45

Emami, B., L. Kaiser, J. Simpson, S. Shapiro, C. Roper, and M. A. Lockett. "Postoperative Radiation Therapy in Non-Small Cell Lung Cancer." American Journal of Clinical Oncology 20, no. 5 (1997): 441–48. http://dx.doi.org/10.1097/00000421-199710000-00003.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

46

王, 妹兴. "Clinical Analysis of Postoperative Adjuvant Therapy in Gastric Cancer." Asian Case Reports in Oncology 04, no. 04 (2015): 32–38. http://dx.doi.org/10.12677/acrpo.2015.44006.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

47

Iyengar, Puneeth, Lawrence B. Levy, Seungtaek Choi, Andrew K. Lee, and Deborah A. Kuban. "Toxicity Associated With Postoperative Radiation Therapy for Prostate Cancer." American Journal of Clinical Oncology 34, no. 6 (2011): 611–18. http://dx.doi.org/10.1097/coc.0b013e3181f946dc.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

48

Hoermann, K. "S8 Postoperative wound complications of therapy for intraoral cancer." Oral Oncology Supplement 2, no. 1 (2007): 59. http://dx.doi.org/10.1016/s1744-7895(07)70046-9.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

49

Picozzi, V. "Novel approaches to postoperative chemoradiation therapy in pancreatic cancer." Journal of Gastrointestinal Surgery 5, no. 1 (2001): 8–9. http://dx.doi.org/10.1016/s1091-255x(01)80004-4.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

50

Vikram, Bhadrasain. "Does Postoperative Radiation Therapy Benefit Patients With Prostate Cancer?" Journal of Clinical Oncology 26, no. 8 (2008): 1392. http://dx.doi.org/10.1200/jco.2007.15.4302.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

Oferecemos descontos em todos os planos premium para autores cujas obras estão incluídas em seleções literárias temáticas. Contate-nos para obter um código promocional único!